University College London at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
University College London brings 19 presentations to ESGCT 2026 in Hamburg. Its groups work on gene editing for inherited immune and metabolic disease and on non-viral delivery, including mRNA therapies for cystic fibrosis and primary ciliary dyskinesia. Further work covers AAV capsid design for muscular dystrophy and generating CAR T cells in the body.
| Organization | ESGCT 2026 Attendance |
|---|---|
University College London London, UK | |
London university with a large gene and cell therapy programme spanning AAV and lentiviral gene therapy, haemophilia and CAR-T trials. | Chair Tue Oct 27 9:30am–11:00am CLINICAL TRIALS AND COMMERCIALISATION WORKSHOP 1 Manufacturing, CMC and accessClinical trials and translation Workshop Tue Oct 27 9:55am–10:45am VLPs for in vivo CAR-T cells Vectors and delivery (AAV, lentiviral, LNP)Cell therapies and CAR-T Chair Tue Oct 27 11:15am–1:00pm CLINICAL TRIALS AND COMMERCIALISATION WORKSHOP 2 Manufacturing, CMC and access Chair Wed Oct 28 8:30am–10:30am SESSION 3b: Hematopoietic & PID Rare and inherited disease Talk Wed Oct 28 9:30am–10:30am Patient-specific gene editing approaches rescue B cell development in X-linked agammaglobulinemia Gene and epigenome editingRare and inherited disease Chair Wed Oct 28 11:00am–12:30pm SESSION 4c: Immunotherapy and CAR T cells II Cell therapies and CAR-T Poster Wed Oct 28 1:30pm–3:30pm BREAKING FREE FROM VIRUSES: TOWARD A SCALABLE NON-VIRAL PLATFORM FOR HSC GENE THERAPY Poster Wed Oct 28 1:30pm–3:30pm Combinatorial CRISPR-activation Gene Therapy to Treat Intractable Epilepsy Poster Wed Oct 28 1:30pm–3:30pm Developing a 3D in vitro model of skeletal muscle involvement in late-onset Pompe disease for CRISPR-based therapy testing Poster Wed Oct 28 1:30pm–3:30pm Development of in vitro transcribed mRNA therapeutics for cystic fibrosis combined with CFTR modulators. Poster Wed Oct 28 1:30pm–3:30pm Improving the gene therapy vector and applying lipidomics to monitor the efficacy of therapy for CLN3 disease. Poster Wed Oct 28 1:30pm–3:30pm Restoration of cilia motility via mRNA therapy in Primary Ciliary Dyskinesia Poster Wed Oct 28 1:30pm–3:30pm The Development of a PEG-bPEI Nanogel-based Delivery System for Nucleic Acids Chair Wed Oct 28 6:00pm–7:00pm SESSION 6: Gene editing Gene and epigenome editing Chair Thu Oct 29 8:30am–10:30am SESSION 7c: Accessibility of GT Manufacturing, CMC and access Talk Thu Oct 29 8:30am–10:30am SESSION 7d: Skin, pulmonary and skeletal diseases Rare and inherited disease Talk Thu Oct 29 12:30pm–1:00pm Prime Time for patients with metabolic diseases Gene and epigenome editingRare and inherited disease Poster Thu Oct 29 2:00pm–4:00pm A two-in-one AAV donor strategy for manufacturing IMiD-switchable anti-B7H3 CAR T cells Poster Thu Oct 29 2:00pm–4:00pm Cleavage-competent sgRNA contaminants and enhanced off-target detection revealed by DNA repair inhibition in genome-edited HSPCs Poster Thu Oct 29 2:00pm–4:00pm Cryo-EM analysis of viral vector heterogeneity Poster Thu Oct 29 2:00pm–4:00pm Mutation, exon or gene; Trade-offs between correction and cell function for different scales of non-viral HDRT ex vivo correction of XLA. Poster Thu Oct 29 2:00pm–4:00pm Rational design AAV capsid engineering for fibroblast-directed targeting towards Collagen VI muscular dystrophy genetic therapies. Chair Fri Oct 30 9:00am–10:30am SESSION 11b: Bleeding disorders Rare and inherited disease Talk Fri Oct 30 9:10am–10:30am Gene therapy in hemophilia Rare and inherited diseaseClinical trials and translation Talk Fri Oct 30 12:00pm–1:00pm A human multi-organoid framework to improve preclinical assessment of AAV gene therapy in neuromuscular disease Vectors and delivery (AAV, lentiviral, LNP)Rare and inherited disease Talk Fri Oct 30 12:15pm–1:00pm Targeted lipid nanocomplex delivery of angiopoietin-1 mRNA slows progression of childhood kidney disease Vectors and delivery (AAV, lentiviral, LNP)RNA and oligonucleotide therapies |
Instantly find 20 buyers from University College London
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction